Novartis gets late stage win for asthma combo

Novartis announced that a Phase 3 trial of QMF149 in patients with uncontrolled asthma has met its primary endpoint.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Asthma | Pharmaceuticals